Sleep Apnea, Obstructive
Respiratory·MeSH: Sleep Apnea, Obstructive
Prevalence
15000.0 / 100K
Incidence
1000.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Eloralintide | ELI LILLY & Co (LLY) |
Frequently asked questions
How many drugs are in development for Sleep Apnea, Obstructive?
BioSniper tracks 1 drug in development for Sleep Apnea, Obstructive across 1 company.
How many clinical trials target Sleep Apnea, Obstructive?
There are 1 clinical trial targeting Sleep Apnea, Obstructive tracked by BioSniper.
What is the prevalence of Sleep Apnea, Obstructive?
The estimated prevalence of Sleep Apnea, Obstructive is approximately 15000.0 per 100,000 population.
Deep-dive into Sleep Apnea, Obstructive
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis